###begin article-title 0
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
Role of ADAMs in the Ectodomain Shedding and Conformational Conversion of the Prion Protein*
###end article-title 0
###begin p 1
Present address: Division of Biomedical and Life Sciences, School of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, United Kingdom.
###end p 1
###begin p 2
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 602 603 602 603 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 603 604 603 604 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</underline>
###xml 615 616 615 616 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 619 620 619 620 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</underline>
###xml 681 682 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 785 786 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1077 1080 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">228</sup>
###xml 1088 1091 1088 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">229</sup>
###xml 1369 1370 1366 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1405 1406 1402 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1414 1416 1411 1413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1553 1555 1550 1552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1608 1609 1605 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1682 1683 1679 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1690 1692 1687 1689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
The cellular prion protein (PrPC) is essential for the pathogenesis and transmission of prion diseases. PrPC is bound to the plasma membrane via a glycosylphosphatidylinositol anchor, although a secreted, soluble form has also been identified. Previously we reported that PrPC is subject to ectodomain shedding from the membrane by zinc metalloproteinases with a similar inhibition profile to those involved in shedding the amyloid precursor protein. Here we have used gain-of-function (overexpression) and loss-of-function (small interfering RNA knockdown) experiments in cells to identify the ADAMs (adisintegrin and metalloproteinases) involved in the ectodomain shedding of PrPC. These experiments revealed that ADAM9 and ADAM10, but not ADAM17, are involved in the shedding of PrPC and that ADAM9 exerts its effect on PrPC shedding via ADAM10. Using dominant negative, catalytically inactive mutants, we show that the catalytic activity of ADAM9 is required for its effect on ADAM10. Mass spectrometric analysis revealed that ADAM10, but not ADAM9, cleaved PrP between Gly228 and Arg229, three residues away from the site of glycosylphosphatidylinositol anchor attachment. The shedding of another membrane protein, the amyloid precursor protein beta-secretase BACE1, by ADAM9 is also mediated via ADAM10. Furthermore, we show that pharmacological inhibition of PrPC shedding or activation of both PrPC and PrPSc shedding by ADAM10 overexpression in scrapie-infected neuroblastoma N2a cells does not alter the formation of proteinase K-resistant PrPSc. Collectively, these data indicate that although PrPC can be shed through the action of ADAM family members, modulation of PrPC or PrPSc ectodomain shedding does not regulate prion conversion.
###end p 2
###begin p 3
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 23 24 23 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN4"><sup>3</sup></xref>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 367 369 367 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 918 918 918 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5"/>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 134 140 <span type="species:ncbi:9606">humans</span>
###xml 153 158 <span type="species:ncbi:9940">sheep</span>
###xml 160 166 <span type="species:ncbi:9913">bovine</span>
###xml 196 202 <span type="species:ncbi:9913">cattle</span>
The prion protein (PrP)3 is the causative agent of the transmissible spongiform encephalopathies such as Creutzfeldt-Jakob disease in humans, scrapie in sheep, bovine spongiform encephalopathy in cattle, and chronic wasting disease in deer and elk (1). In these diseases the cellular form of PrP (PrPC) undergoes a conformational conversion to the infectious form PrPSc that is characterized biochemically by its resistance to digestion with proteinase K (PK) (2). Mature PrPC is anchored to the extracellular surface of the cell membrane through a glycosylphosphatidylinositol (GPI) anchor and, like most GPI-anchored proteins, is clustered into cholesterol-rich, detergent-resistant membrane rafts (reviewed in Ref. 3). Although the precise subcellular site of conversion remains undefined, conformational conversion of PrPC to PrPSc is believed to occur either at the cell surface or within the endocytic pathway (4-6).
###end p 3
###begin p 4
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 462 464 462 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 615 617 615 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 700 701 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 984 985 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1065 1072 1065 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1076 1081 <span type="species:ncbi:9606">human</span>
A number of studies indicate that modulation of PrPC levels at the cell surface may represent a possible future disease intervention strategy. For example, the retention of PrPC at the cell surface and concomitant prevention of its endocytosis through the use of PrP antibodies inhibited PrPSc formation (7). Furthermore, the sterol-binding polyene antibiotic filipin reduced endocytosis, and induced cellular release, of PrPC with a concomitant reduction in PrPSc accumulation (8). More recently, it has been shown that modulation of cell surface PrPC levels by the novel sorting nexin SNX33 can interfere with PrPSc formation in cultured cells (9). Nonetheless, the natural processes regulating PrPC levels at the cell surface remain poorly defined. One such mechanism of regulation is via shedding of the bulk of the ectodomain of PrPC either through cleavage of the polypeptide close to the GPI anchor or within the GPI anchor itself. Indeed, it has long been established that PrPC can be shed into the medium of cultured cells and is present as a soluble form in vivo in human cerebrospinal fluid (10, 11).
###end p 4
###begin p 5
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 550 551 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 812 814 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 944 945 936 937 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 945 946 937 938 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</underline>
###xml 957 958 949 950 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</underline>
###xml 961 962 953 954 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</underline>
###xml 1039 1041 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1239 1241 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1347 1349 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Numerous cell surface proteins can be proteolytically shed by the action of a group of zinc metalloproteinases known collectively as secretases or sheddases (reviewed in Refs. 12, 13). Whereas most proteolytically shed proteins are derived from transmembrane polypeptide-anchored substrates, several GPI-anchored proteins, including the folate receptor (14), the ecto-ADP-ribosyltransferase ART2.2 (15), and a GPI-anchored construct of angiotensin-converting enzyme (16) are shed by the action of metalloproteinases. We have previously shown that PrPC can also be proteolytically shed from the cell surface through the action of one or more zinc metalloproteinases with similar properties to those of the alpha-secretases responsible for the shedding of the amyloid precursor protein (APP) of Alzheimer disease (17). This alpha-secretase-mediated ectodomain shedding of APP from the cell surface is carried out by at least three members of the adisintegrin and metalloproteinase (ADAM) family, namely ADAM9, -10, and -17 (reviewed in Ref. 18). In addition to cleavage by ADAMs, APP is also cleaved by the beta-secretase, BACE1 (beta-site APP-cleaving enzyme) and the gamma-secretase complex to release the neurotoxic amyloid-beta peptide (19). BACE1 itself is also subject to ectodomain shedding by as yet unidentified members of the ADAM family (20).
###end p 5
###begin p 6
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 411 414 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">231</sup>
###xml 577 579 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 631 632 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 694 696 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 698 700 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
The similarities between the ectodomain shedding of APP and PrPC, in particular the similar profile of inhibition by a range of hydroxamate-based zinc metalloproteinase inhibitors (17), led us to investigate whether the same members of the ADAM family were also involved in the shedding of PrPC. It should be noted that this ectodomain shedding of PrPC by cleavage of the polypeptide chain near to the site (Ser231) of GPI anchor addition in the C terminus of the protein is distinct from the so-called alpha-cleavage between residues 111 and 112 in the middle of the protein (21, 22). This latter "endoproteolytic" cleavage of PrPC is reported to be carried out by members of the ADAM family (23, 24).
###end p 6
###begin p 7
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 399 400 399 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 455 457 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
To investigate the role of ADAMs in the ectodomain shedding of PrPC, we used loss-of-function and gain-of-function experiments in cultured cells in which candidate PrP sheddases were either knocked down by siRNA or overexpressed. We have also further characterized the shedding of BACE1 by comparison to the shedding of APP and PrPC. In addition, we have explored whether proteolytic shedding of PrPC is of importance in regulating its conversion into PrPSc.
###end p 7
###begin title 8
EXPERIMENTAL PROCEDURES
###end title 8
###begin title 9

###end title 9
###begin title 10

###end title 10
###begin title 11
Antibodies
###end title 11
###begin p 12
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 170 176 <span type="species:ncbi:10090">murine</span>
###xml 499 504 <span type="species:ncbi:9606">human</span>
###xml 632 637 <span type="species:ncbi:9606">human</span>
Antibody 3F4 (Cambridge Bioscience Ltd., Cambridge, UK) recognizes the 3F4 epitope tag (corresponding to amino acid residues 109-112 of human PrP) at residues 108-111 of murine PrP. Antibody SAF-32 (Cayman Chemical, Ann Arbor, MI) recognizes the octapeptide repeats in the N-terminal half of PrP. The epitope for antibody 6D11 (Eurogentec Ltd., Southampton, UK) falls within amino acids 93-109 of PrP. Antibody 6H4 (Prionics AG, Schlieren, Switzerland) recognizes the amino acid sequence DYEDRYYRE (human PrP: amino acids 144-152). Antibody 6E10 (Cambridge Bioscience Ltd., Cambridge, UK) recognizes amino acid residues 1-17 of the human amyloid-beta sequence within APP. Antibody Ab54 was kindly provided by Dr. I. Hussain (GlaxoSmithKline, Harlow, UK) and recognizes the C terminus of APP. Anti-ADAM9, anti-ADAM10, and anti-ADAM17 antibodies were from Merck. The anti-actin antibody (AC15) and the anti-BACE1 antibody (EE17) were from Sigma.
###end p 12
###begin title 13
Recombinant Proteins
###end title 13
###begin p 14
###xml 12 18 <span type="species:ncbi:10090">murine</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Recombinant murine PrP (residues 23-231) was from Allprion AG (Schlieren, Switzerland). Recombinant human ADAM9 and ADAM10 were purchased from R & D Systems (Abingdon, UK).
###end p 14
###begin title 15
Cell Culture
###end title 15
###begin p 16
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 216 218 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 243 245 243 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 255 256 255 256 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 335 336 329 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 446 447 439 440 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 969 970 962 963 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 973 974 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 977 978 970 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 983 984 976 977 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 988 989 981 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 991 992 984 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 999 1000 992 993 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1109 1110 1102 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1159 1160 1152 1153 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1176 1177 1169 1170 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 179 185 <span type="species:ncbi:9913">bovine</span>
Human embryonic kidney (HEK), mouse neuroblastoma N2a, and scrapie-infected N2a cells (ScN2a) (25) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (50 units ml-1), streptomycin (50 mg ml-1), and 2 mm glutamate (all from Invitrogen). Cells were maintained at 37 degreesC in 5% CO2 in air. GW0264 (provided by Dr. I. Hussain, GlaxoSmithKline, Harlow, UK) was used at a concentration of 10 mum. For all HEK cell incubations, the medium was changed at confluence to Opti-MEM (Invitrogen), and the cells were incubated for 5 h with the indicated compounds. For N2a and ScN2a cell incubations, the medium was changed at confluence to Opti-MEM, and the cells were incubated for 24 h with the indicated compounds. The medium was then harvested and concentrated 50-fold using Vivaspin 6 concentrators (Sartorius, Epsom, UK). For analysis of cell-associated proteins, cells were washed with phosphate-buffered saline (20 mm Na2HPO4, 2 mm NaH2PO4, 0.15 m NaCl, pH 7.4) and scraped from the flasks into phosphate-buffered saline. Following centrifugation at 500 x g for 5 min, the pelleted cells were lysed in 0.1 m Tris-HCl, 0.15 m NaCl, 1% (v/v) Triton X-100, 0.1% (v/v) Nonidet P-40, pH 7.4.
###end p 16
###begin title 17
Stable cDNA Transfections
###end title 17
###begin p 18
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hyg</italic>
###xml 285 287 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 21 27 <span type="species:ncbi:10090">murine</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
cDNA encoding either murine PrP (containing a 3F4 tag at amino acid residues 108-111) (26) in the mammalian expression vector pIRESneo (Invitrogen) or human BACE1 in the vector pIREShyg were introduced into HEK cells by electroporation. Recombinant cells were selected using 500 mug ml-1 gentamycin sulfate (G418; Sigma) or hygromycin, respectively.
###end p 18
###begin title 19
Transient cDNA and siRNA Transfections
###end title 19
###begin p 20
###xml 573 574 572 573 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 128 134 <span type="species:ncbi:10090">murine</span>
###xml 142 148 <span type="species:ncbi:9913">bovine</span>
###xml 160 166 <span type="species:ncbi:10090">murine</span>
HEK or ScN2a cells (at 80% confluence) were transiently transfected with 8 mug of pcDNA3.1b containing the cDNA encoding either murine ADAM9, bovine ADAM10, or murine ADAM17 using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were used 36 h post-transfection. For siRNA treatments, HEK cells were grown to 60% confluence in antibiotic-free growth medium and transfected with siRNA duplexes (Eurogentec Ltd., Southampton, UK) using DharmaFECT-1 (Dharmacon) according to the manufacturer's instructions. Cells were transfected with 100 nm duplexes targeted to ADAM9 (sense sequences: duplex 1, 5'-GUGCACAGCUAGUUCUAAAdTdT-3'; duplex 2, 5'-GGAGGAAACUGCCUUCUUAdTdT-3'; or duplex 3 5'-GAGGAUUGCUGCAUUUAGAdTdT-3'); or ADAM10 (sense sequences: 5'-GCCAAGUUCUUGAGAAGAAdTdT-3', 5'-GAUAUCCAGUCAUGUUAAAdTdT-3', and 5'-CUGGAAUUAUUACUGUUCAdTdT-3'). Control cells were subjected to transfection with control Smartpool siRNA (Dharmacon). Cells were used 48 h post-transfection.
###end p 20
###begin title 21
Generation of Catalytically Inactive ADAM9 and ADAM10
###end title 21
###begin p 22
###xml 57 63 <span type="species:ncbi:10090">murine</span>
###xml 74 80 <span type="species:ncbi:9913">bovine</span>
Catalytically inactive dominant negative (dn) mutants of murine ADAM9 and bovine ADAM10 were generated by site-directed mutagenesis using the QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA). The mutagenic primer sequences were as follows: dnAD9 E348A 5'-CATCCATTGTTGCTCATGCATTGGGGCATAACCTTGG-3' and dnAD10 E384A 5'- CTCACATTACGTTTGCTCATGCAGTTGGACATAACTTTGGATC-3'. Mutants were verified by DNA sequencing (The Sequencing Service, Dundee, UK).
###end p 22
###begin title 23
Protein Assay and Enzyme Treatments
###end title 23
###begin p 24
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 177 178 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 205 206 204 205 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 209 210 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 213 214 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 218 219 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 221 222 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 236 237 235 236 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 452 453 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 763 764 740 741 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 58 64 <span type="species:ncbi:9913">bovine</span>
Protein was quantified using bicinchoninic acid (27) with bovine serum albumin as standard. Peptide:N-glycosidase F deglycosylation was performed by adding 40 mul of 5x peptide:N-glycosidase F buffer (30 mm Na2HPO4/NaH2PO4, pH 7.2, 20 mm EDTA) to 200 mug of cell lysate along with 5 mul of 10% (w/v) SDS and 5 mul of beta-mercaptoethanol. The samples were boiled for 5 min and then 20% (v/v) Triton X-100 (5 mul) was added along with 1 unit of peptide:N-glycosidase F. Samples were then deglycosylated for 16 h at 37 degreesC. For PK digestion, 200 mug of cell lysate protein in a volume of 200 mul was incubated for 30 min at 37 degreesC with 5 mug of PK. The reaction was stopped by the addition of phenylmethanesulfonyl fluoride to a final concentration of 3 mm. Protein was precipitated by the addition of 800 mul of ice-cold methanol, incubation overnight at 4 degreesC, pelleted by centrifugation, and then resuspended in electrophoresis sample buffer prior to SDS-PAGE.
###end p 24
###begin title 25
SDS-PAGE and Immunoelectrophoretic Blot Analysis
###end title 25
###begin p 26
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Samples were mixed with an equal volume of reducing electrophoresis sample buffer and boiled for 3 min. Proteins were resolved by SDS-PAGE using 7-17% polyacrylamide gradient gels and transferred to Immobilon P polyvinylidene difluoride membranes as described previously (28). Antibodies were used at the following dilutions: 3F4 at 1:4000; SAF-32 at 1:3000; 6D11 at 1:10,000; 6H4 at 1:20,000; 6E10 at 1:2500; Ab54 at 1:10,000; anti-ADAM9, -10, and -17 at 1:2000; EE17 at 1:2500; and the anti-actin antibody at 1:5000. Bound antibody was detected using peroxidase-conjugated secondary antibodies in conjunction with the enhanced chemiluminescence detection method (Amersham Biosciences).
###end p 26
###begin title 27
Quantitative RT-PCR Analysis
###end title 27
###begin p 28
To monitor endogenous ADAM9 expression, RNA from cell samples was extracted using TRIzol (Invitrogen). Samples containing 1 mug of RNA were then subjected to total cDNA strand synthesis followed by ADAM9 or beta-actin amplification using Titanium one-step RT-PCR kit (Clontech). The ADAM9 primer sequences were as follows: 5'- GCTAGTTGGACTGGAGATTTGG-3' and 5'-TTATTACCACAGGAGGGAGCAC-3' giving a PCR product of 486 bp. The actin primers were those provided with the Titanium kit. RT-PCR products were resolved on an agarose gel containing ethidium bromide.
###end p 28
###begin title 29
Mass Spectrometry
###end title 29
###begin p 30
###xml 108 109 107 108 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 117 118 116 117 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 143 144 141 142 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 149 150 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 328 329 320 321 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 926 928 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 979 981 964 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
To assess cleavage of PrP by ADAM9 and ADAM10, recombinant PrP was diluted to a final concentration of 10 mum in 25 mm Tris-HCl, pH 9.0, 2.5 mum ZnCl2, 0.005% (v/v) Brij-35. Samples were incubated in the presence or absence of 200 ng of recombinant ADAM9 or ADAM10 for 3 h at 37 degreesC. Samples were then drop dialyzed into 1 m ammonium acetate, and subsequently, 5 mul of sample was diluted to 1:1 (v/v) methanol, 0.1% aqueous formic acid and analyzed by Z-spray nanoelectrospray ionization MS using a quadrupole-ion mobility spectrometry-orthogonal time-of-flight MS (Synapt HDMS, Waters). The MS was operated in positive TOF mode using a capillary voltage of 1.0 kV, cone voltage of 50 V, nanoelectrospray nitrogen gas pressure of 0.1 bar, and backing pressure of 2.01 mbar. The source and desolvation temperatures were set at 80 and 150 degreesC, respectively. Nitrogen was used as buffer gas, at a pressure of 7.87 x 10-3 mbar in the trap and transfer regions and 3.1 x 10-4 mbar in the ion mobility spectrometry cell. Mass calibration was performed by a separate injection of sodium iodide at a concentration of 2 mug/mul. Data processing was performed using the MassLynx version 4.1 suite of software supplied with the mass spectrometer.
###end p 30
###begin title 31
ADAM Activity Assay
###end title 31
###begin p 32
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 236 237 235 236 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 245 246 244 245 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 271 272 269 270 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 277 278 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 416 417 413 414 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
The activity of recombinant ADAM9 and ADAM10 was assessed using a fluorogenic peptide substrate Mca-Pro-Leu-Ala-Gln-Ala-Val-Dpa-Arg-Ser-Ser-Ser-Arg-NH2 (R & D Systems). The peptide substrate was diluted to a final concentration of 10 mum in 25 mm Tris-HCl, pH 9.0, 2.5 mum ZnCl2, 0.005% (v/v) Brij-35 and incubated, where indicated, with 200 pg of ADAM9 or ADAM10, and the inhibitor GW4023 (final concentration 10 mum). Peptide cleavage was monitored using an OptiPlate fluorescence plate reader (PerkinElmer Life Sciences) with excitation at 310 nm and emission at 400 nm.
###end p 32
###begin title 33
Statistical Analysis
###end title 33
###begin p 34
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical analysis was performed using unpaired t tests for pairwise comparison in all instances. Significance was assigned when p </= 0.05.
###end p 34
###begin title 35
RESULTS
###end title 35
###begin title 36

###end title 36
###begin title 37

###end title 37
###begin title 38
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
PrPC Is Shed by ADAM9 and ADAM10
###end title 38
###begin p 39
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 208 214 208 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 263 269 263 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 639 645 639 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 645 646 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
To determine whether the same ADAM family members responsible for shedding APP could also shed PrPC, we transiently transfected cDNAs encoding ADAM 9, ADAM10, or ADAM17 into HEK cells stably expressing PrPC (Fig. 1). Immunoblot analysis of ADAM9 in cell lysates (Fig. 1A) revealed a number of nonspecific bands along with an increased intensity of two immunoreactive bands at 110 and 84 kDa representing the prodomain containing and mature forms of ADAM9, respectively, consistent with previous studies (24, 29). The anti-ADAM10 antibody detected a nonspecific band at 105 kDa, which was also present in the mock-transfected cell lysates (Fig. 1A), along with a specific band at 90 kDa that corresponds to the prodomain containing form of ADAM10 in agreement with previous reports (24, 30). The prodomain containing form of ADAM17 was detected as a 110-kDa immunoreactive band consistent with a previous report (30).
###end p 39
###begin p 40
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Shedding of PrP<sup>C</sup> is enhanced by ADAM9 and ADAM10.</bold>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD17</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 614 615 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 620 621 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 718 719 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 744 745 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Shedding of PrPC is enhanced by ADAM9 and ADAM10. HEK cells stably expressing PrPC were transiently transfected with either empty vector (Mock) or the cDNAs encoding ADAM9 (AD9), ADAM10 (AD10), or ADAM17 (AD17). Transfected cells were incubated for 5 h in serum-free medium before harvesting the conditioned medium and preparing cell lysates. A, immunodetection of ADAMs in cell lysates. B, immunodetection of PrPC (antibody 3F4), APP (antibody Ab54), and actin in cell lysates. C, immunodetection of sPrP in conditioned medium (antibody 3F4). D, immunodetection of sAPPalpha in conditioned media (antibody 6E10). C and D, multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3). *, significant at p </= 0.05.
###end p 40
###begin p 41
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 112 118 112 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 280 286 280 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 433 439 429 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 439 440 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 531 537 523 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 539 540 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 545 546 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 688 690 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 797 798 789 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
The levels of cell-associated PrPC and APP were not significantly altered by co-expression of any of the ADAMs (Fig. 1B). However, co-expression of ADAM9 and ADAM10 significantly enhanced the release of shed PrP (sPrP) into conditioned medium (1.44- and 1.55-fold, respectively) (Fig. 1C). Similarly, ADAM9 and ADAM10 significantly enhanced the shedding of sAPPalpha into the conditioned medium by 1.32- and 1.65-fold, respectively (Fig. 1D). Expression of ADAM17 had no significant effect on the shedding of sPrP or of sAPPalpha (Fig. 1, C and D), even though this construct of ADAM17 has been shown to increase the shedding of another membrane protein, angiotensin-converting enzyme-2 (31). These data indicate that ADAM9 and ADAM10, but not ADAM17, are capable of shedding the ectodomain of PrPC.
###end p 41
###begin p 42
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 458 464 458 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 669 675 669 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 805 811 805 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 881 882 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 910 916 910 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 918 919 918 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 924 925 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1074 1080 1074 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1080 1081 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1202 1208 1202 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1208 1209 1208 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1313 1319 1309 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1321 1322 1317 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1327 1328 1323 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1418 1419 1414 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
To confirm that ADAM9 and ADAM10 were responsible for the shedding of PrPC, siRNAs were employed to knock down the expression of endogenous ADAM9 and ADAM10 in the HEK cells. Three individual duplexes were targeted to both ADAM9 and ADAM10, with a commercially available control Smartpool siRNA reagent used as a control. As the anti-ADAM9 antibody did not detect endogenous ADAM9 in the HEK cells because of the high amount of nonspecific bands recognized (Fig. 1A), its knockdown was confirmed by RT-PCR. The siRNA duplexes against ADAM9 reduced its expression by between 78.7 and 89.2% depending on the duplex used, but it had no effect on the expression of ADAM10 (Fig. 2A). The siRNA duplexes against ADAM10 reduced its expression by between 66.5 and 79.3%, but it had no effect on ADAM9 expression (Fig. 2D). Neither knockdown of ADAM9 nor of ADAM10 altered the amount of PrPC or APP in the cell lysate (Fig. 2, A and D). However, knockdown of ADAM9 reduced the amount of sPrP in the conditioned medium by 21.0, 26.2, and 24.1% for duplexes 1, 2, and 3, respectively (Fig. 2B). Knockdown of ADAM10 by the ADAM10-specific duplexes 1-3 reduced sPrP shedding by 44.6, 53.5, and 64.5%, respectively (Fig. 2E). Similar reductions in the shedding of sAPPalpha by knockdown of ADAM9 and ADAM10 were also observed (Fig. 2, C and F). These data confirm that endogenous ADAM9 and ADAM10 are involved in the shedding of PrPC.
###end p 42
###begin p 43
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Knockdown of ADAM9 and ADAM10 by siRNA reduces the shedding of PrP<sup>C</sup>.</bold>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</italic>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D&#8211;F</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 440 441 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 548 549 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 572 573 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 578 579 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 753 754 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 779 780 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 791 795 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ctrl</italic>
Knockdown of ADAM9 and ADAM10 by siRNA reduces the shedding of PrPC. HEK cells stably expressing PrPC were transiently transfected with one of three different siRNA duplexes to either ADAM9 (AD9) (A-C) or ADAM10 (AD10) (D-F) as detailed under "Experimental Procedures." Transfected cells were incubated for 5 h in serum-free medium before harvesting the conditioned medium and preparing cell lysates. A and D, immunodetection of ADAM10, PrPC, APP, and actin in cell lysates. ADAM9 was detected by semi-quantitative RT-PCR. Immunodetection of sPrP (B and E) and sAPPalpha (C and F) in conditioned medium using antibodies 3F4 and 6E10, respectively, is shown. Multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3). *, significant at p </= 0.05. Ctrl, control.
###end p 43
###begin title 44
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
Shedding of PrPC by ADAM9 Is Mediated via ADAM10
###end title 44
###begin p 45
###xml 96 97 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 186 188 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 291 292 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 359 365 351 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 365 366 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 532 538 520 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 540 541 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 546 547 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 755 761 739 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 763 764 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 769 770 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 813 814 797 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
It has been reported that ADAM9 mediates its effect on the endoproteolytic alpha-cleavage of PrPC and the alpha-secretase cleavage of APP indirectly, through modulating ADAM10 activity (24). To determine whether this was also the situation for the involvement of ADAM9 in the shedding of PrPC, we expressed ADAM9 in the presence of siRNA knockdown of ADAM10 (Fig. 3A). As before, expression of ADAM9 led to an increase in the shedding of both sPrP and sAPPalpha, and siRNA knockdown of ADAM10 reduced the shedding of both proteins (Fig. 3, B and C). In the presence of the siRNA knockdown of ADAM10, expression of ADAM9 did not lead to an increase in the shedding of either sPrP or sAPPalpha above that seen in the presence of the ADAM10 knockdown alone (Fig. 3, B and C). These data show that the shedding of PrPC, similarly to the shedding of sAPPalpha, by ADAM9 is dependent on the presence of ADAM10.
###end p 45
###begin p 46
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Knockdown of ADAM10 by siRNA inhibits the increased shedding of PrP<sup>C</sup> by ADAM9.</bold>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 306 309 306 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 571 572 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 746 747 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 772 773 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 784 787 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O/E</italic>
Knockdown of ADAM10 by siRNA inhibits the increased shedding of PrPC by ADAM9. HEK cells stably expressing PrPC were transiently transfected with or without ADAM10 (AD10) siRNA duplexes as detailed under "Experimental Procedures." After 18 h cells were transfected with or without the cDNA encoding ADAM9 (AD9). After a further 25 h, cells were incubated for 5 h in serum-free medium before harvesting the conditioned medium and preparing cell lysates. A, immunodetection of ADAM9, ADAM10, PrPC, APP, and actin in cell lysates. Immunodetection of sPrP (B) and sAPPalpha (C) in conditioned medium using antibodies 3F4 and 6E10, respectively, is shown. Multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3). *, significant at p </= 0.05. O/E, overexpressing.
###end p 46
###begin title 47
Modulation of ADAM10 by ADAM9 Requires the Proteolytic Activity of ADAM9
###end title 47
###begin p 48
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 539 545 535 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 635 641 631 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 641 642 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 774 780 766 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 782 783 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 788 789 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 967 968 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
To further investigate the mechanism by which ADAM10 activity is modulated by ADAM9, the requirement for the proteolytic activity of ADAM9 was assessed. Catalytically inactive dn mutants of ADAM9 and ADAM10 were generated by mutating the conserved catalytic Glu residue in the zinc-binding His-Glu-Xaa-Xaa-His motif of the enzymes to Ala (32, 33). The mutants were then transfected into HEK cells, and the effect of their expression on the shedding of sPrP and sAPPalpha was assessed, relative to wild-type ADAM9 and ADAM10 transfectants (Fig. 4). Both mutants were expressed to similar levels as the corresponding wild-type proteins (Fig. 4A). However, neither dnADAM9 nor dnADAM10 led to an increase in the detection of either sPrP or sAPPalpha in the conditioned medium (Fig. 4, B and C). These data indicate an absolute requirement for the proteolytic activity of ADAM9 in its modulation of ADAM10 activity and for the catalytic activity of ADAM10 in shedding PrPC.
###end p 48
###begin p 49
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteolytic activities of both ADAM9 and ADAM10 are required for the shedding of PrP<sup>C</sup>.</bold>
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnAD9</italic>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dnAD10</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 573 574 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 579 580 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 677 678 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 703 704 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 715 718 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O/E</italic>
Proteolytic activities of both ADAM9 and ADAM10 are required for the shedding of PrPC. HEK cells stably expressing PrPC were transiently transfected with either empty vector (Mock) or the cDNAs encoding ADAM9 (AD9), dnADAM9 (dnAD9), ADAM10, or dnADAM10 (dnAD10). Transfected cells were incubated for 5 h in serum-free medium after which the conditioned medium was harvested and cell lysates prepared. A, immunodetection of ADAMs, PrPC, APP, and actin in cell lysates. B, immunodetection of sPrP in conditioned medium. C, immunodetection of sAPPalpha in conditioned medium. B and C, multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3). *, significant at p </= 0.05. O/E, overexpressing.
###end p 49
###begin title 50
ADAM10, but Not ADAM9, Cleaves Recombinant PrP
###end title 50
###begin p 51
###xml 335 341 335 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 446 452 446 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 609 615 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1010 1013 1010 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">228</sup>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">229</sup>
###xml 1182 1183 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1258 1259 1258 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1271 1274 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">228</sup>
###xml 1282 1285 1282 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">229</sup>
###xml 1354 1357 1354 1357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">231</sup>
###xml 1359 1365 1359 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1365 1366 1365 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1568 1574 1568 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1574 1575 1574 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1762 1763 1762 1763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
To further understand the cleavage of PrP by the ADAMs family members, recombinant PrP was incubated with recombinant ADAM9 or ADAM10, and the samples were analyzed by nanoelectrospray ionization mass spectrometry. The mass spectrum from rPrP yielded a charge state distribution of ions corresponding to a single species of 23,161 Da (Fig. 5A). Similarly, in the sample digested with ADAM9, only peaks corresponding to intact rPrP were observed (Fig. 5A). However, in the ADAM10-digested sample, in addition to peaks corresponding to a molecular mass of 23,161 Da, a second species of 22,675 Da was observed (Fig. 5A). No species of this molecular weight was observed on the spectrum of recombinant ADAM10 alone (data not shown), indicating that the 22,675 Da species was generated by the ADAM10-mediated cleavage of rPrP. Analysis of the N- and C-terminal sequences of rPrP indicated that the 22,675 Da species was the result of a 4-amino acid C-terminal truncation of rPrP, with cleavage occurring at the Gly228-Arg229 peptide bond in the C-terminal rPrP sequence QAYYDGRRSS (it should be noted that rPrP has an additional Ser residue at the C terminus as compared with mature PrPC). Thus, this lower molecular weight species corresponds to cleavage of PrPC between Gly228 and Arg229, three residues N-terminal to the site of GPI anchor addition at Ser231 (Fig. 5B). To confirm that the recombinant ADAM9 was catalytically active, the enzyme was assayed with a quenched fluorescent peptide substrate. Both recombinant ADAM9 and ADAM10 cleaved the peptide substrate (Fig. 5C). These data indicate that ADAM10, but not ADAM9, can directly cleave PrP close to the site of GPI anchor attachment, strengthening the hypothesis that the ADAM9-mediated shedding of PrPC occurs though modulation of ADAM10 activity.
###end p 51
###begin p 52
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM10, but not ADAM9, cleaves recombinant PrP.</bold>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 92 93 91 92 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 360 363 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 388 392 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 578 579 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 580 581 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 602 603 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 605 606 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sup>
###xml 605 606 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>n</sup></italic>
###xml 606 607 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 635 636 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 743 744 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 772 773 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 858 859 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1030 1031 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1133 1134 1118 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1141 1144 1126 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mca</italic>
###xml 1181 1182 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1182 1186 1167 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</sup>
###xml 1207 1208 1189 1190 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
ADAM10, but not ADAM9, cleaves recombinant PrP.A, recombinant PrP (final concentration 10 mum) was incubated with 200 ng of recombinant ADAM9 or ADAM10 for 3 h at 37 degreesC. Samples were then prepared for analysis by nanoelectrospray mass spectrometry as described under "Experimental Procedures." Nanoelectrospray mass spectra of rPrP only, rPrP with ADAM9(AD9), and rPrP with ADAM10 (AD10) showing the 9+ and 8+ charge state envelope are shown. PrP () is present in all samples, and the proteolytically cleaved product () is present in the ADAM10-treated sample only. The m/z ratios for the [M + nH]n+ signals are labeled, where n is the charge state; adjacent signals correspond to sodium substitution adducts of the protonated signal. B, C-terminal sequence of PrPC showing the site of GPI anchor addition and the determined cleavage site by ADAM10. C, activity of recombinant ADAM9 and ADAM10 was assessed by measuring the cleavage of a fluorogenic peptide substrate Mca-Pro-Leu-Ala-Gln-Ala-Val-Dpa-Arg-Ser-Ser-Ser-Arg-NH2 for 3 h at 37 degreesC in the presence or absence of the inhibitor GW4023. Values are mean +/- S.D. (n = 3). Mca, 7,4-methoxycoumarin-4-acetyl; Dpa, Nbeta-(2,4-dinitrophenyl)-l-2,3-diaminopropionic acid.
###end p 52
###begin title 53
Shedding of BACE1 by ADAM9 Is Also Mediated via ADAM10
###end title 53
###begin p 54
###xml 132 134 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 136 138 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 140 142 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 312 314 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 642 648 639 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 650 651 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 656 657 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 806 812 803 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 814 815 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 820 821 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 854 855 851 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1009 1015 1002 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1015 1016 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1161 1167 1154 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1167 1168 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1358 1359 1351 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 105 110 <span type="species:ncbi:9606">human</span>
Shed forms of the Alzheimer disease beta-secretase BACE1 have been identified in both cultured cells and human cerebrospinal fluid (20, 34, 35). Based on the observation that BACE1 shedding was sensitive to specific zinc metalloproteinase inhibitors, it was concluded that ADAM10 was a candidate BACE1 sheddase (20). To confirm that ADAM10 was involved in the shedding of BACE1 and to explore the role of ADAM9 in the shedding of this protein, HEK cells expressing BACE1 were transfected with the cDNAs encoding either ADAM9 or ADAM10. The level of cell-associated BACE1 was not significantly altered by co-expression of either of the ADAMs (Fig. 6, A and B). However, expression of ADAM9 or ADAM10 enhanced the release of shed BACE1 (sBACE1) into the conditioned medium (2.3- and 7.8-fold, respectively) (Fig. 6, A and B). To determine whether, like PrPC and APP, AlphaDAM9 was shedding BACE1 via modulation of ADAM10, HEK cells were transfected with ADAM9 cDNA in the presence of siRNA knockdown of ADAM10 (Fig. 6C). The increase in the shedding of sBACE1 observed upon expression of ADAM9 was inhibited to control levels in the presence of the ADAM10 siRNA (Fig. 6D). These data indicate that both ADAM9 and ADAM10 are capable of shedding BACE1 and that the ADAM9-mediated shedding of BACE1 requires the presence of ADAM10, as seen for the shedding of PrPC and APP.
###end p 54
###begin p 55
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM9 and -10 are involved in the shedding of BACE1.</bold>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 843 844 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 907 908 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1065 1066 1063 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1091 1092 1089 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1103 1106 1099 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O/E</italic>
ADAM9 and -10 are involved in the shedding of BACE1. HEK cells stably expressing BACE1 were transiently transfected with either empty vector (Mock) or the cDNAs encoding either ADAM9 (AD9) or ADAM10 (AD10). Transfected cells were incubated for 5 h in serum-free medium before harvesting the conditioned medium and preparing cell lysates. Immunodetection of overexpressed ADAM9 (A) or ADAM10 (B) along with BACE1 and actin in cell lysates and sBACE1 in conditioned medium is shown. HEK cells stably expressing BACE1 were transiently transfected with or without ADAM10 siRNA duplexes as detailed under "Experimental Procedures." After 18 h cells were transfected with or without the cDNA encoding ADAM9. After a further 25 h, cells were incubated for 5 h in serum-free medium before harvesting the conditioned medium and preparing cell lysates. C, immunodetection of ADAM9, ADAM10, and actin in cell lysates. D, immunodetection of BACE1 in lysates and conditioned medium. Multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3). *, significant at p </= 0.05. O/E, overexpressing.
###end p 55
###begin title 56
###xml 101 102 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
ADAM9, -10, and -17 Are Not Responsible for the Cell-associated Endoproteolytic alpha-Cleavage of PrPC
###end title 56
###begin p 57
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 174 177 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">111</sup>
###xml 185 188 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
###xml 277 279 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 397 398 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 400 402 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 404 406 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 532 533 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 604 605 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 741 747 737 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 747 748 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 873 874 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 876 882 872 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 882 883 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1039 1040 1031 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
In addition to the juxtamembrane cleavage of PrPC, which occurs during ectodomain shedding, the protein is also subject to endoproteolytic alpha-cleavage between residues His111 and Met112 to yield N- and C-terminal fragments (termed N1 and C1, respectively) (reviewed in Ref. 22). Previously it has been reported that ADAM9 and -10 are involved in the constitutive endoproteolytic cleavage of PrPC (23, 24). To investigate this in our system, lysates from cells expressing either ADAM9, ADAM10, or ADAM17 were subjected to peptide:N-glycosidase F deglycosylation, to permit resolution of full-length PrPC from its C1 fragment. Expression of any of the three ADAMs did not significantly affect the amount of C1 fragment in the cell lysates (Fig. 7A). Furthermore, siRNA depletion of either ADAM9 or ADAM10 did not alter the amount of C1 fragment relative to full-length PrPC (Fig. 7B). Collectively, these data indicate that ADAM9, -10, and -17 are not responsible for the cell-associated constitutive endoproteolytic alpha-cleavage of PrPC.
###end p 57
###begin p 58
###xml 81 82 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 0 83 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM9, -10, and -17 are not involved in the endoproteolytic &#945;-cleavage of PrP<sup>C</sup>.</bold>
###xml 115 116 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 160 164 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 195 198 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD9</italic>
###xml 209 213 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 227 231 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD17</italic>
###xml 234 235 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 282 283 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 391 393 387 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FL</italic>
###xml 398 399 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 571 572 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
ADAM9, -10, and -17 are not involved in the endoproteolytic alpha-cleavage of PrPC. HEK cells stably expressing PrPC were transfected with either empty vector (Mock) or the cDNAs encoding ADAM9 (AD9), ADAM10 (AD10), or ADAM17 (AD17) (A) or siRNA targeted to either ADAM9 or ADAM10 (B). Cell lysates were prepared and deglycosylated as described under "Experimental Procedures." Full-length (FL) PrPC and its C1 fragment in cell lysates were immunodetected using antibody 6H4. Multiple immunoblots were quantified by densitometric analysis. Results are the mean +/- S.D. (n = 3).
###end p 58
###begin title 59
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
Modulation of ADAM-mediated PrPC Shedding Does Not Alter PrPSc Formation
###end title 59
###begin p 60
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 192 192 192 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8"/>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 346 348 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 477 479 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 811 817 811 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 817 818 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 834 836 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 942 948 942 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 948 949 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1044 1046 1044 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1126 1127 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1134 1136 1134 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1201 1203 1199 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1231 1237 1229 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 1237 1238 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1276 1277 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1427 1433 1425 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 1433 1434 1431 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1479 1480 1477 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1508 1510 1506 1508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
There is accumulating evidence indicating that the level of PrPC at the cell surface or the amount of PrPC that is subsequently endocytosed is a strong determinant in the formation of PrPSc (7-9, 36). Molecular mechanisms capable of regulating the amount of PrPC at the cell surface might therefore be of critical importance in the control of PrPSc propagation. Consequently, we sought to determine whether modulation of ADAM-mediated cell surface PrPC shedding would alter PrPSc formation using two approaches. First, scrapie-infected ScN2a mouse neuroblastoma cells (25) were incubated with the hydroxamate-based inhibitor GW0264, a potent inhibitor of ADAM10 that has >100-fold reduced potency toward ADAM17 (20). Shedding of sPrP from the ScN2a cells was inhibited by 77.3% following treatment with GW0264 (Fig. 8A). To detect PrPSc, cell lysates were digested with PK prior to SDS-PAGE and subsequent immunoblotting using antibody 6D11 (Fig. 8B). Incubation of the cells for 96 h with GW0264 had no effect on the amount of PK-resistant PrPSc, whereas incubation with Congo red, which is known to prevent conversion of PrPC to PrPSc (37), resulted in a 76.1 +/- 10.7% reduction of PK-resistant PrPSc over the same time period (Fig. 8B). To confirm that the shedding of PrPC had been inhibited in the ScN2a cells over this extended time period, conditioned medium samples from each day of incubation were analyzed for sPrP (Fig. 8C). These data indicate that inhibition of PrPC shedding does not alter PrPSc formation.
###end p 60
###begin p 61
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inhibition of PrP<sup>C</sup> shedding does not alter PrP<sup>Sc</sup> formation.</bold>
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 141 142 140 141 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 206 207 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 279 280 277 278 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 362 364 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 615 616 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 660 662 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 796 797 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1079 1080 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Inhibition of PrPC shedding does not alter PrPSc formation.A, ScN2a cells were incubated for 12 h in the absence or presence of GW0264 (10 mum). sPrP in conditioned medium was detected using antibody 6D11. B, ScN2a cells were incubated in the presence or absence of GW0264 (10 mum) for 96 h (inhibitor was replaced every 12 h). As a positive control for anti-PrPSc activity, cells were treated with 1 mug/ml Congo red for 96 h (with media replaced every 12 h). Cells were harvested, lysed, and digested with PK as described under "Experimental Procedures." Immunoblotting for PrP was performed using antibody 6D11. C, densitometric analysis of PK-resistant PrPSc levels for each treatment, relative to those of mock-treated cells, from multiple blots from three independent experiments is shown. D, to confirm that shedding had been inhibited in ScN2a cells treated with GW0264 for 4 days, medium samples from each day of incubation were pooled and then concentrated. Equal volumes of concentrated medium were resolved by SDS-PAGE and immunoblotted using 6D11. *, significant at p </= 0.05.
###end p 61
###begin p 62
###xml 427 433 425 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 433 434 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 527 529 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 604 610 602 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 610 611 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 758 760 756 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 817 823 815 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 825 826 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 831 832 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 941 943 937 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1003 1009 999 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 1011 1012 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1017 1018 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1080 1081 1076 1077 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1089 1091 1085 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1139 1141 1135 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
In the second approach, ScN2a cells were transiently transfected with the cDNA encoding ADAM10 and then left for 96 h to assess whether shedding of PrP was increased in this cell line and whether this increased shedding could modulate prion conversion. When cells were transfected with the cDNA encoding ADAM10, there was a significant increase in both expression of ADAM10 (272.6 +/- 18.5%) and in the shedding of total sPrP (Fig. 9A). When medium samples were treated with PK prior to analysis, the amount of PK-resistant PrPSc shed into the medium was also increased in cells transfected with ADAM10 (Fig. 9A). However, when cell lysate samples were digested with PK to assess the effect of ADAM10 overexpression on the total cell load of PK-resistant PrPSc, no change was observed in cells overexpressing ADAM10 (Fig. 9, B and C). Again, Congo red was used as a positive control to show that a 79.3 +/- 6.0% reduction in PK-resistant PrPSc could be achieved over the time course of this experiment (Fig. 9, B and C). These data indicate that promoting the shedding of both PrPC and PrPSc by ADAM10 does not modulate cell-associated PrPSc formation.
###end p 62
###begin p 63
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM10 overexpression increases the shedding of PrP<sup>C</sup> and PrP<sup>Sc</sup> but does not alter prion conversion.</bold>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AD10</italic>
###xml 272 273 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 678 679 677 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 793 795 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 830 831 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 875 877 874 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1066 1067 1065 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
ADAM10 overexpression increases the shedding of PrPC and PrPSc but does not alter prion conversion. ScN2a cells were transiently transfected with empty vector (Mock) or the cDNA encoding ADAM10 (AD10) or treated with 1 mug/ml Congo red. The cells were then left for 96 h. A, 12 h prior to the end of the experiment, the medium was replaced with serum-free medium before harvesting the conditioned medium and preparing cell lysates. Immunodetection of PrP, ADAM10, and actin in cell lysates is shown. Medium samples were concentrated and then treated with PK, where indicated. Equal volumes of concentrated medium were resolved by SDS-PAGE and immunoblotted using 6D11 for sPrP. B, cells were harvested, lysed, and digested with PK as described under "Experimental Procedures." PK-resistant PrPSc was detected using antibody 6D11. C, densitometric analysis of PK-resistant PrPSc levels of ADAM10-transfected and Congo red-treated cells, relative to those of mock-treated cells. Data from multiple blots from three independent experiments are shown. *, significant at p </= 0.05.
###end p 63
###begin title 64
DISCUSSION
###end title 64
###begin p 65
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 230 231 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 887 888 887 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1038 1039 1038 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1190 1191 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
Whereas shed forms of PrP have long been identified both in vitro and in vivo, it was thought that this shedding was the result of the action of a phospholipase on the GPI anchor of PrPC (11, 38). Proteolysis as a mechanism of PrPC ectodomain shedding was first hypothesized with the observation that the mobility of secreted PrPC was not altered after treatment with aqueous hydrofluoric acid as would be expected had the protein been shed by the action of a phospholipase (10). Confirming that PrPC can be proteolytically shed, we have previously shown that a range of hydroxamate-based zinc metalloprotease inhibitors have an identical inhibitory profile in relation to PrPC shedding and the shedding of APP (17), strongly suggesting that the two proteins are shed by the same protease(s). Here we have extended that study and directly assessed the roles of ADAM9, -10, and -17 in PrPC shedding by direct comparison to APP shedding. We show that overexpression of either ADAM9 or ADAM10, but not of ADAM17, enhances the shedding of PrPC. Using siRNA-mediated depletion of endogenous ADAM9 and -10, we were able to confirm that these two proteases were responsible for the shedding of PrPC at least in cell culture models.
###end p 65
###begin p 66
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 14 16 14 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 697 698 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 941 942 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1218 1222 1218 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
Koike et al. (39) showed that co-expression of ADAM9 with APP in COS cells enhanced production of soluble APP and made the logical conclusion that the catalytic activity of ADAM9 was directly responsible for APP shedding. However, it has since been demonstrated that ADAM9 enhances APP shedding in an indirect fashion via stimulation of ADAM10 activity (24). Using the novel approach of overexpression of ADAM9 in the presence of siRNA knockdown of ADAM10, we were able to confirm that ADAM9 exerts its effect on APP shedding by modulation of ADAM10. Furthermore, we were able to demonstrate that this phenomenon is not restricted to the ADAM9-mediated shedding of APP, as the shedding of both PrPC and BACE1 by ADAM9 was also dependent on ADAM10. In addition, we have shown that the proteolytic activity of ADAM9 is critical for its ability to modulate ADAM10, as a catalytically inactive mutant of ADAM9 did not enhance the shedding of PrPC, and that ADAM9 on its own was unable to cleave recombinant PrP. These results raise the question as to whether ADAM9 directly cleaves and sheds other membrane proteins or always acts via ADAM10. In the light of this, the role of ADAM9 in the shedding of other "substrates," e.g. Kit ligand, p75 neurotrophin receptor, Delta-like ligand-1, and pro-epidermal growth factor (40), may need to be revisited.
###end p 66
###begin p 67
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 368 370 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 557 559 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 561 563 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 600 602 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Recently, both ADAM9 and ADAM15 have been shown to proteolytically cleave ADAM10 releasing the ectodomain into the extracellular medium (41). The resulting membrane-bound stub was then subject to cleavage by gamma-secretase, and the intracellular domain translocated to the nucleus, providing evidence that ADAM10 itself undergoes regulated intramembrane proteolysis (41). It is unclear whether the soluble ectodomain of ADAM10 is capable of cleaving membrane-bound substrates, and although it was catalytically active against synthetic peptide substrates (41, 42), it was incapable of shedding APP (42).
###end p 67
###begin p 68
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 474 475 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 482 483 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 525 526 525 526 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 636 638 636 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 772 775 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">228</sup>
###xml 777 779 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 870 872 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1065 1067 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1176 1178 1164 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1190 1197 1178 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1250 1252 1238 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1273 1276 1261 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">228</sup>
###xml 1280 1283 1268 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">229</sup>
###xml 1376 1378 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1422 1424 1410 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1477 1478 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1510 1512 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 998 1006 <span type="species:ncbi:9606">patients</span>
Shedding of the ectodomain of PrPC by ADAM10 would require cleavage of the polypeptide chain close to the site of the GPI anchor attachment. Mass spectrometric analysis showed that this is indeed the case, with recombinant ADAM10 cleaving PrP three residues upstream of the Ser residue to which the GPI anchor is attached (43). Cleavage at this site is consistent with known ADAM10 cleavage sites in other substrates, in particular that basic residues are preferred at the P1' and P2' sites and Ser is strongly preferred at P3'. Interestingly, the analysis of C-terminal peptides derived from endoproteinase Lys-C digests of hamster PrPSc revealed that although the majority of the molecules were GPI anchored, approximately15% had a C-terminal peptide that ended with Gly228 (43), consistent with cleavage at this site by ADAM10. Recently, an anchorless fragment of PrPSc, which lacks a few amino acids at the very end of the C terminus together with the GPI anchor, was detected in the brains of patients with both sporadic and variant Creutzfeldt-Jakob disease (44). In light of the data presented in this study it is possible that these C-terminally truncated forms of PrPSc identified in vivo are a result of the action of ADAM10 in shedding PrPSc. Cleavage at the Gly228-Arg229 bond is also consistent with our previous data that sPrP was recognized by the R1 antibody (17) whose epitope is within residues 220-231 (45). Recently, a novel 9-kDa C-terminal fragment of PrPC, termed C3, has been reported (46). This C3 fragment does not appear to correspond to the C-terminal fragment following ectodomain shedding by ADAM10, as its generation was inhibited by E64, and it was recognized by the antibody R1, suggesting that C3 is cleaved upstream of residue 220 by a cysteine protease.
###end p 68
###begin p 69
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 151 152 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 184 187 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">111</sup>
###xml 195 198 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
###xml 318 319 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 509 511 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 513 515 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 720 721 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 806 807 798 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 901 902 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 930 932 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1303 1304 1291 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
In addition to the proteolysis of PrPC within its juxtamembrane region, we also examined the role of ADAMs in the endoproteolytic alpha-cleavage of PrPC between amino acid residues His111 and Met112. We show that both overexpression of ADAM9, -10, and -17 and depletion of ADAM9 and -10 did not alter levels of the PrPC proteolytic fragment C1 in HEK cell lysates. These results appear to contradict previous reports that demonstrated an increase in N1 secretion from HEK cells overexpressing the same ADAMs (23, 24). However, these previous studies examined only the secretion of a minor pool of N1 into conditioned medium and did not examine the effect of the ADAMs on the cell-associated production of proteolytic PrPC fragments. Recently, we have reported that the endoproteolytic alpha-cleavage of PrPC occurs predominantly in a late compartment of the secretory pathway, prior to full-length PrPC reaching the cell surface (47). In this study we have examined cell-associated levels of C1, as opposed to secreted N1, and we show that ADAM9, -10, and -17 overexpression, and ADAM9 and -10 depletion, did not affect the production of the former fragment. These data indicate that alternative unidentified proteinases are responsible for the bulk cell-associated endoproteolytic alpha-cleavage of PrPC.
###end p 69
###begin p 70
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 259 266 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 684 685 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 693 695 693 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 918 919 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 927 929 927 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 950 952 950 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1093 1094 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1101 1103 1101 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 1275 1276 1275 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 1296 1298 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
For the first time, we have examined the effect of modulating proteolytic ectodomain shedding of PrPC on the production of PrPSc in scrapie-infected N2a cells. As PrPC transport to the cell surface and/or its subsequent endocytosis appears to be required for de novo PrPSc production (7, 8), it might be expected that the inhibition of PrPC shedding and the subsequent accumulation of the protein at the cell surface would promote PrPSc formation. Conversely, one might expect that enhanced shedding of PrPC would reduce the amount of PrPC substrate at the cell surface available for prion conversion. However, although) PrPC shedding was clearly inhibited by GW0264 treatment and PrPC and PrPSc shedding were increased by ADAM10 overexpression, we observed no concomitant alteration in the accumulation of proteinase K-resistant PrPSc in the ScN2a cells. These data imply that alterations to the basal shedding of PrPC and PrPSc do not influence PrPSc formation, at least in this cell system. One possible explanation for this lack of effect of altering the proteolytic shedding of either PrPC or PrPSc on the conversion process is because the shedding by ADAM10 affects only a minority of the membrane-bound protein, whereas cleavage by phospholipase C or exposure to a PrPC-specific antibody (48) affects a larger proportion of the membrane-bound protein, thus impacting on the conversion process.
###end p 70
###begin p 71
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 93 95 93 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 543 545 543 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 861 862 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
From the observation that SNX33 overexpression increased the shedding of PrPC and reduced PrPSc conversion, it was concluded that modulation of PrPC shedding may represent a novel therapeutic approach in the treatment of prion diseases (9). However, this explanation may be oversimplified as these authors also demonstrated that SNX33 overexpression impaired the endocytic trafficking of PrPC. As the endocytic pathway is a suggested site of prion conversion (4, 49, 50), it may be through blocking this that SNX33 affects the formation of PrPSc. By modulation of one of the proteinases, ADAM10, directly responsible for PrPC and PrPSc shedding, our data argue that subtle modulation of PrP shedding is unlikely to offer a new avenue for therapeutic strategies for the treatment of prion diseases. Nevertheless, the precise dissection of the cell biology of PrPC by studies such as these provides a realistic avenue toward the development of new treatments for prion diseases by increasing our understanding of the cellular processes governing prion conversion.
###end p 71
###begin p 72
This work was supported by Medical Research Council of Great Britain Grant G9824728, Wellcome Trust Grant 080229/Z/06/Z, and the University of Leeds.
###end p 72
###begin p 73
###xml 28 31 28 31 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">PrP</term>
###xml 31 44 31 44 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="74">prion protein</p>
###xml 31 44 31 44 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="74">prion protein</p></def>
###xml 28 44 28 44 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">PrP</term><def><p textid="74">prion protein</p></def></def-item>
###xml 44 48 44 48 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">ADAM</term>
###xml 48 81 48 81 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="75">a disintegrin and metalloprotease</p>
###xml 48 81 48 81 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="75">a disintegrin and metalloprotease</p></def>
###xml 44 81 44 81 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">ADAM</term><def><p textid="75">a disintegrin and metalloprotease</p></def></def-item>
###xml 81 84 81 84 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">APP</term>
###xml 84 109 84 109 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="76">amyloid precursor protein</p>
###xml 84 109 84 109 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="76">amyloid precursor protein</p></def>
###xml 81 109 81 109 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">APP</term><def><p textid="76">amyloid precursor protein</p></def></def-item>
###xml 109 114 109 114 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">BACE1</term>
###xml 114 145 114 142 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="77">&#946;-site APP-cleaving enzyme-1</p>
###xml 114 145 114 142 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="77">&#946;-site APP-cleaving enzyme-1</p></def>
###xml 109 145 109 142 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">BACE1</term><def><p textid="77">&#946;-site APP-cleaving enzyme-1</p></def></def-item>
###xml 145 148 142 145 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">GPI</term>
###xml 148 176 145 173 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="78">glycosylphosphatidylinositol</p>
###xml 148 176 145 173 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="78">glycosylphosphatidylinositol</p></def>
###xml 145 176 142 173 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">GPI</term><def><p textid="78">glycosylphosphatidylinositol</p></def></def-item>
###xml 176 179 173 176 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">HEK</term>
###xml 179 201 176 198 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="79">human embryonic kidney</p>
###xml 179 201 176 198 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="79">human embryonic kidney</p></def>
###xml 176 201 173 198 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">HEK</term><def><p textid="79">human embryonic kidney</p></def></def-item>
###xml 201 203 198 200 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">MS</term>
###xml 203 220 200 217 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="80">mass spectrometry</p>
###xml 203 220 200 217 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="80">mass spectrometry</p></def>
###xml 201 220 198 217 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">MS</term><def><p textid="80">mass spectrometry</p></def></def-item>
###xml 220 222 217 219 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">PK</term>
###xml 222 234 219 231 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="81">proteinase K</p>
###xml 222 234 219 231 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="81">proteinase K</p></def>
###xml 220 234 217 231 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">PK</term><def><p textid="81">proteinase K</p></def></def-item>
###xml 237 238 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 234 238 231 235 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">PrP<sup>C</sup></term>
###xml 238 258 235 255 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="82">cellular form of PrP</p>
###xml 238 258 235 255 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="82">cellular form of PrP</p></def>
###xml 234 258 231 255 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">PrP<sup>C</sup></term><def><p textid="82">cellular form of PrP</p></def></def-item>
###xml 261 263 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sc</sup>
###xml 258 263 255 260 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">PrP<sup>Sc</sup></term>
###xml 263 295 260 292 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="83">proteinase-resistant form of PrP</p>
###xml 263 295 260 292 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="83">proteinase-resistant form of PrP</p></def>
###xml 258 295 255 292 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">PrP<sup>Sc</sup></term><def><p textid="83">proteinase-resistant form of PrP</p></def></def-item>
###xml 295 299 292 296 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">rprP</term>
###xml 299 314 296 311 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">recombinant PrP</p>
###xml 299 314 296 311 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="84">recombinant PrP</p></def>
###xml 295 314 292 311 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">rprP</term><def><p textid="84">recombinant PrP</p></def></def-item>
###xml 314 323 311 316 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">sAPP&#945;</term>
###xml 323 380 316 369 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">soluble form of APP derived from &#945;-secretase cleavage</p>
###xml 323 380 316 369 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">soluble form of APP derived from &#945;-secretase cleavage</p></def>
###xml 314 380 311 369 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">sAPP&#945;</term><def><p textid="85">soluble form of APP derived from &#945;-secretase cleavage</p></def></def-item>
###xml 380 386 369 375 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">sBACE1</term>
###xml 386 404 375 393 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">shed form of BACE1</p>
###xml 386 404 375 393 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">shed form of BACE1</p></def>
###xml 380 404 369 393 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">sBACE1</term><def><p textid="86">shed form of BACE1</p></def></def-item>
###xml 404 407 393 396 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G14">SNX</term>
###xml 407 420 396 409 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">sorting nexin</p>
###xml 407 420 396 409 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">sorting nexin</p></def>
###xml 404 420 393 409 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G14">SNX</term><def><p textid="87">sorting nexin</p></def></def-item>
###xml 420 424 409 413 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G15">sPrP</term>
###xml 424 440 413 429 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">shed form of PrP</p>
###xml 424 440 413 429 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">shed form of PrP</p></def>
###xml 420 440 409 429 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G15">sPrP</term><def><p textid="88">shed form of PrP</p></def></def-item>
###xml 440 442 429 431 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G16">RT</term>
###xml 442 463 431 452 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="89">reverse transcription</p>
###xml 442 463 431 452 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="89">reverse transcription</p></def>
###xml 440 463 429 452 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G16">RT</term><def><p textid="89">reverse transcription</p></def></def-item>
###xml 463 468 452 457 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G17">siRNA</term>
###xml 468 489 457 478 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">small interfering RNA</p>
###xml 468 489 457 478 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">small interfering RNA</p></def>
###xml 463 489 452 478 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G17">siRNA</term><def><p textid="90">small interfering RNA</p></def></def-item>
###xml 489 491 478 480 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G18">dn</term>
###xml 491 509 480 498 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="91">dominant negative.</p>
###xml 491 509 480 498 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="91">dominant negative.</p></def>
###xml 489 509 478 498 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G18">dn</term><def><p textid="91">dominant negative.</p></def></def-item>
###xml 28 509 28 498 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">PrP</term><def><p textid="74">prion protein</p></def></def-item><def-item><term id="G2">ADAM</term><def><p textid="75">a disintegrin and metalloprotease</p></def></def-item><def-item><term id="G3">APP</term><def><p textid="76">amyloid precursor protein</p></def></def-item><def-item><term id="G4">BACE1</term><def><p textid="77">&#946;-site APP-cleaving enzyme-1</p></def></def-item><def-item><term id="G5">GPI</term><def><p textid="78">glycosylphosphatidylinositol</p></def></def-item><def-item><term id="G6">HEK</term><def><p textid="79">human embryonic kidney</p></def></def-item><def-item><term id="G7">MS</term><def><p textid="80">mass spectrometry</p></def></def-item><def-item><term id="G8">PK</term><def><p textid="81">proteinase K</p></def></def-item><def-item><term id="G9">PrP<sup>C</sup></term><def><p textid="82">cellular form of PrP</p></def></def-item><def-item><term id="G10">PrP<sup>Sc</sup></term><def><p textid="83">proteinase-resistant form of PrP</p></def></def-item><def-item><term id="G11">rprP</term><def><p textid="84">recombinant PrP</p></def></def-item><def-item><term id="G12">sAPP&#945;</term><def><p textid="85">soluble form of APP derived from &#945;-secretase cleavage</p></def></def-item><def-item><term id="G13">sBACE1</term><def><p textid="86">shed form of BACE1</p></def></def-item><def-item><term id="G14">SNX</term><def><p textid="87">sorting nexin</p></def></def-item><def-item><term id="G15">sPrP</term><def><p textid="88">shed form of PrP</p></def></def-item><def-item><term id="G16">RT</term><def><p textid="89">reverse transcription</p></def></def-item><def-item><term id="G17">siRNA</term><def><p textid="90">small interfering RNA</p></def></def-item><def-item><term id="G18">dn</term><def><p textid="91">dominant negative.</p></def></def-item></def-list>
The abbreviations used are: PrPprion proteinADAMa disintegrin and metalloproteaseAPPamyloid precursor proteinBACE1beta-site APP-cleaving enzyme-1GPIglycosylphosphatidylinositolHEKhuman embryonic kidneyMSmass spectrometryPKproteinase KPrPCcellular form of PrPPrPScproteinase-resistant form of PrPrprPrecombinant PrPsAPPalphasoluble form of APP derived from alpha-secretase cleavagesBACE1shed form of BACE1SNXsorting nexinsPrPshed form of PrPRTreverse transcriptionsiRNAsmall interfering RNAdndominant negative.
###end p 73
###begin p 74
prion protein
###end p 74
###begin p 75
a disintegrin and metalloprotease
###end p 75
###begin p 76
amyloid precursor protein
###end p 76
###begin p 77
beta-site APP-cleaving enzyme-1
###end p 77
###begin p 78
glycosylphosphatidylinositol
###end p 78
###begin p 79
###xml 0 5 <span type="species:ncbi:9606">human</span>
human embryonic kidney
###end p 79
###begin p 80
mass spectrometry
###end p 80
###begin p 81
proteinase K
###end p 81
###begin p 82
cellular form of PrP
###end p 82
###begin p 83
proteinase-resistant form of PrP
###end p 83
###begin p 84
recombinant PrP
###end p 84
###begin p 85
soluble form of APP derived from alpha-secretase cleavage
###end p 85
###begin p 86
shed form of BACE1
###end p 86
###begin p 87
sorting nexin
###end p 87
###begin p 88
shed form of PrP
###end p 88
###begin p 89
reverse transcription
###end p 89
###begin p 90
small interfering RNA
###end p 90
###begin p 91
dominant negative.
###end p 91
###begin title 92
REFERENCES
###end title 92

